Fifty patients with iron-deficiency anaemia were treated by total-dose infusion of iron-dextran. The therapeutic response was satisfactory in all cases. No severe systemic side effects occurred. In ten patients in whom detailed investigations were made there was no change in erythrocyte sedimentation rate or blood coagulation nor was there evidence of haemolysis following the iron-dextran infusion. No difficulty was found in ABO and Rh blood grouping and cross matching after infusion.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.